Darunavir
Potent boosted protease inhibitor for HIV with resistance.
- Starts working
- Weeks
- Half-life
- About 15 hours (boosted)
- In use since
- —
- Pregnancy
- Use with caution
Overview
Darunavir is taken with ritonavir or cobicistat. It keeps working against many resistant HIV strains and is used in second- or third-line regimens.
Conditions it's used for
How it works
Stops HIV from maturing into infectious viruses.
Darunavir belongs to the Viral protease inhibitors. How Viral protease inhibitors work: block the viral 'scissors' enzyme, so the long protein chain the virus makes cannot be cut into working pieces.
Uses
- HIV infection (with other drugs)
Available as: tablet, oral suspension, combination tablets.
Typical dose
- Adults
- 800 mg with 100 mg ritonavir once a day (600/100 mg twice a day if resistant).
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Diarrhoea
- Nausea
- Headache
- Rash
Serious — get medical help
Uncommon, but need prompt attention
- Severe skin reactions
- Liver injury
- Raised cholesterol and glucose
Warnings
- Contains a sulfonamide group
- Take with food
Who should avoid it
- Severe liver disease
- Taking simvastatin or rifampicin
- Allergy to sulfonamides (caution)
Interactions
- Simvastatin, lovastatin — contraindicated
- Rivaroxaban, apixaban — raised levels
- Hormonal contraceptives — may be less reliable
- Rifampicin — contraindicated
Other medicines in the atlas that need care with Darunavir, grouped by the reason:
Dangerous rise in drug levelsMajorWith Ciclosporin, Colchicine, Fentanyl, Midazolam, Simvastatin and 3 more
A strong CYP3A4 inhibitor blocks breakdown of a drug where higher levels are hazardous (e.g. simvastatin — muscle breakdown; colchicine — fatal toxicity; tacrolimus — kidney damage; fentanyl or midazolam — breathing suppression).
What's usually done: Usually contraindicated or needs a planned pause or major dose change. Always check with a pharmacist.
Colchicine toxicityMajorWith Colchicine
Transporter inhibition can raise colchicine exposure; toxicity may cause severe diarrhoea, muscle injury, bone-marrow suppression or organ failure.
What's usually done: Avoid many combinations, especially with kidney or liver disease. Use a lower dose only under specialist advice.
Digoxin toxicityMajorWith Digoxin
P-glycoprotein inhibition can raise digoxin levels, increasing the risk of nausea, visual changes, confusion and dangerous heart rhythms.
What's usually done: Check the digoxin level and kidney function; a dose reduction may be needed.
Raised drug levelsModerateWith Abiraterone, Alfuzosin, Alprazolam, Amlodipine, Apixaban and 57 more
Blocking CYP3A4 increases levels of this medicine, so side effects become more likely.
What's usually done: A dose reduction, alternative or extra monitoring may be needed.
Higher rhythm riskModerateWith Amiodarone, Amisulpride, Amitriptyline, Artemether–lumefantrine, Azithromycin and 38 more
Some CYP3A4 inhibitors raise concentrations of QT-prolonging medicines, adding to the risk of torsades and fainting.
What's usually done: Avoid high-risk combinations where possible; review the specific medicine and consider ECG monitoring.
Low blood sugarModerateWith Glibenclamide, Gliclazide, Glimepiride, Glipizide
Some CYP3A4 inhibitors increase exposure to sulfonylureas, making hypoglycaemia more likely.
What's usually done: Check glucose more often and review the diabetes dose when the inhibitor starts or stops.
More anticoagulant effectModerateWith Dabigatran, Edoxaban
P-glycoprotein inhibition can raise levels of some oral anticoagulants and increase bleeding.
What's usually done: Check the product label and use an alternative or closer bleeding surveillance when appropriate.
INR may riseModerateWith Warfarin
Some CYP3A4 inhibitors can slow warfarin metabolism and increase anticoagulant effect.
What's usually done: Check INR soon after starting or stopping the inhibitor and adjust warfarin only through the anticoagulation service.
Using it safely
- Alcohol
- Best to limit. Alcohol adds to liver strain.
- Food and drink
- Take with food.
- If you miss a dose
- Take when remembered with food; skip if near the next dose.
- Stopping it
- Do not stop without advice.
- Driving
- Dizziness possible.
- Tests and checks
- Viral load; Liver tests; Lipids; Glucose
- If too much is taken
- Seek help; supportive care.
- Storage
- Room temperature.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Use with caution
Limited data; only if essential.
Breastfeeding
Usually avoided
Not recommended where safe formula is available.
Special groups
- Liver disease
- Avoid in severe impairment.
- Older adults
- Standard dosing.
Brand names
- United States
- Prezista, Prezcobix
- United Kingdom
- Prezista, Rezolsta
- India
- Prezista, Darunavir (generic)
- Australia
- Prezista
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Darunavir?
Yes — Darunavir is prescription-only in most countries.
Can I take Darunavir during pregnancy?
Use with caution. Limited data; only if essential. Always check with a doctor or midwife.
How quickly does Darunavir work?
Weeks.
Related medicines
Lopinavir-ritonavir
Boosted protease inhibitor for HIV, mostly used as a second-line option.
RxWHOViral protease inhibitorsDolutegravir
Core of the WHO-preferred HIV treatment.
RxWHOIntegrase inhibitorsTenofovir disoproxil
Backbone drug for HIV treatment, PrEP and hepatitis B.
RxWHONucleos(t)ide reverse transcriptase inhibitorsNirmatrelvir–ritonavir
COVID-19 antiviral pills for people at high risk.
RxViral protease inhibitors
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — J05AE10
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.